Removal of gadolinium-based contrast agents: adsorption on activated carbon
Three carbon samples were employed in this work, including commercial (1690 m 2 g −1 ), activated carbon prepared from guava seeds (637 m 2 g −1 ), and activated carbon prepared from avocado kernel (1068 m 2 g −1 ), to study the adsorption of the following gadolinium-based contrast agents (GBCAs)...
Gespeichert in:
Veröffentlicht in: | Environmental science and pollution research international 2017-03, Vol.24 (9), p.8164-8175 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Three carbon samples were employed in this work, including commercial (1690 m
2
g
−1
), activated carbon prepared from guava seeds (637 m
2
g
−1
), and activated carbon prepared from avocado kernel (1068 m
2
g
−1
), to study the adsorption of the following gadolinium-based contrast agents (GBCAs): gadoterate meglumine Dotarem®, gadopentetate dimeglumine Magnevist®, and gadoxetate disodium Primovist®. The activation conditions with H
3
PO
4
were optimized using a Taguchi methodology to obtain mesoporous materials. The best removal efficiency by square meter in a batch system in aqueous solution and model urine was achieved by avocado kernel carbon, in which mesoporosity prevails over microporosity. The kinetic adsorption curves were described by a
pseudo
-second-order equation, and the adsorption isotherms in the concentration range 0.5–6 mM fit the Freundlich equation. The chemical characterization of the surfaces shows that materials with a greater amount of phenolic functional groups adsorb the GBCA better. Adsorption strongly depends on the pH due to the combination of the following factors: contrast agent protonated forms and carbon surface charge. The tested carbon samples were able to adsorb 70–90% of GBCA in aqueous solution and less in model urine. This research proposes a method for the elimination of GBCA from patient urine before its discharge into wastewater. |
---|---|
ISSN: | 0944-1344 1614-7499 |
DOI: | 10.1007/s11356-017-8491-x |